{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-024947","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.641603+00:00","generated_at":"2026-05-31T12:45:17.939617+00:00","sec_items":["1.01","2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NRC Health Q2 revenue $35M, EPS $0.26; amends credit; acquires NOBL Health","bullets":["Q2 revenue ~$35M vs ~$36M YoY; diluted EPS $0.26 vs $0.29 YoY; TRCV $138M at June 30.","Credit agreement amended: maturity extended to May 2027; term loans bear SOFR+2.35% with 10-year amort.","Acquired NOBL Health on July 15 for ~$6M cash + up to $1M earnout; NOBL had ~$2M TRCV.","Board declared $0.12/share quarterly dividend, payable Oct 11, record Sep 27.","~1.1M shares remain under repurchase plan; no buybacks in Q2 pending amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-024947","json":"https://secwatch.observer/filing/0001437749-24-024947.json","markdown":"https://secwatch.observer/filing/0001437749-24-024947.md","text":"https://secwatch.observer/filing/0001437749-24-024947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774924024947/0001437749-24-024947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774924024947/nrc20240806_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:45:17.939617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}